Bodor Laboratories, Inc. was established to further develop the portfolio of therapeutics designed to have significantly enhanced safety through utilizing the Retrometabolic Drug Design & Delivery (RMDD) concepts invented by Prof. Dr. Nicholas S. Bodor.
This concept has resulted in numerous patents that have led to novel drugs in development and on the market that have demonstrated efficacy and dramatically superior safety.
Our portfolio of intellectual property provides opportunities to develop therapies in dermatology, ophthalmology, respiratory, and other applications to treat a variety of disease states.
Bodor Laboratories, Inc. Founded in 2006 By Prof. Nicholas S. Bodor to Further the Development and Therapeutic Potential of his Novel Retrometabolic Drug Design and Targeting Concepts.
About Us
We have utilized this drug design approach to build a substantive portfolio of intellectual property, which we are able to develop through collaborative partnerships to drive these ideas to the market.